Hearscape
← Devices & Neurotechnology
Details checkedStrong evidenceCheckedcompany

MED-EL BONEBRIDGE BCI 602

Also known as: BONEBRIDGE, BCI 602, MED-EL bone conduction implant

MED-EL

Primary source
Company
MED-EL
Program Type
Device
Modality
Cochlear/Auditory Implant
Stage
Marketed
Status
Marketed
Target Gene
—
Route / Mode
Implantable bone-conduction system with external processor
Confidence
84%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-05-31
Geography
Europe, United States, Global
Population
pediatric, adult, unilateral, bilateral
Trial IDs
0
Mechanism

An active bone-conduction implant that transmits sound through bone to the cochlea for patients with conductive or mixed loss and selected unilateral indications.

Indications
Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss
Notes

Important active bone-conduction platform and major competitor to Cochlear Osia/Baha in conductive and mixed hearing-loss implant workflows.

Evidence & Sources
2 structured sources
company
Supports: canonicalName, aliases, company, notes, keyEvents
Open
company
Supports: programType, modality, indications, status, geography
Open
Key Events
2021-01-01
MED-EL published corporate information on the BONEBRIDGE BCI 602 launch and surgical update
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed